Activ Surgical is a U.S.-based developer of digital health technologies dedicated to improving the efficiency, accuracy, patient outcomes and accessibility of endoscopy and surgical-assist robotics. Activ Surgical’s scalable and patent-protected surgical software platform technology is powered by computer vision, artificial intelligence analytics and machine learning to improve surgeons’ decision-making accuracy during surgery and reduce unexpected and preventable surgical complications, The company’s ActivSight is an advanced software and sensing platform that works dynamically and seamlessly to “activate” installed surgical visualization and robotic systems to provide clinicians worldwide with real-time intraoperative visualization data and images . A few days ago, multinational pharmaceutical company Hikma Pharmaceuticals PLC announced that its venture capital Hikma Ventures has led a $15 million financing in digital surgical imaging startup Activ Surgical. According to reports, this investment is an expansion of Activ Surgical’s Series B financing completed in September 2021 and brings the overall Series B financing to $60 million.
This article is reproduced from: https://www.itjuzi.com/investevent/13177638
This site is for inclusion only, and the copyright belongs to the original author.